MedTrace Logo

Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia

NCT05456152 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 358

Last updated 2023-09-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of sublingual zolpidem during the long-term treatment of insomnia.

Conditions

  • Chronic Insomnia

Interventions

DRUG

Sublingual Tablet

Sublingual zolpidem - 1 sublingual tablet 30 minutes before bed time.

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-30
Primary Completion
2025-01-31
Completion
2025-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05456152 on ClinicalTrials.gov